Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

Fusion Pharmaceuticals Q3 EPS $(0.45) Down From $(0.24) YoY

Fusion Pharmaceuticals (NASDAQ:FUSN) reported quarterly losses of $(0.45) per share. This is a 87.5 percent decrease over losses of $(0.24) per share from the same period last year.
byBenzinga Newsdesk
November 9, 2021
1 minute read
Total
0
Shares
0
0
0
0
0
0

Fusion Pharmaceuticals (NASDAQ:FUSN) reported quarterly losses of $(0.45) per share. This is a 87.5 percent decrease over losses of $(0.24) per share from the same period last year.

 
Total
0
Shares
Share 0
Tweet 0
Share 0
Share 0
Share 0
Share 0
Related Posts